<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001427'>Mitochondrial</z:hpo> dysfunctions generating from <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfusion exert a potential threat on neuronal cell survival and hence, accelerate the aging process and age dependent neuropathology </plain></SENT>
<SENT sid="1" pm="."><plain>Thirty min moderate <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> induced by bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> (BCCAO) followed by 30 min reperfusion caused an increased diene production, depleted <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSH) content, reduced <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD) and catalase activities and pyramidal <z:hpo ids='HP_0002529'>neuronal loss</z:hpo> in young (2 months old) and aged (20 months old) rat brain compared to sham operated controls </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="17562">Cytidine</z:chebi> 5' diphosphocholine (<z:chebi fb="0" ids="16436,49086">CDP-Choline</z:chebi>) is a known neuroprotective drug </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="16436,49086">CDP-Choline</z:chebi> after metabolism in the liver suffers hydrolysis and splits into <z:chebi fb="0" ids="17562">cytidine</z:chebi> and <z:chebi fb="3" ids="15354">choline</z:chebi> before entering systemic circulation and hardly circumvents blood brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) as such </plain></SENT>
<SENT sid="4" pm="."><plain>Previous reports show <z:chebi fb="0" ids="16436,49086">CDP-Choline</z:chebi> liposomes significantly increased in vivo uptake compared to "free drug" administration in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>To enhance the therapeutic concentration build up in brain we sought to formulate mannosylated liposomal <z:chebi fb="0" ids="16436,49086">CDP-Choline</z:chebi> (MLCDP) utilizing the <z:chebi fb="0" ids="37684">mannose</z:chebi> receptors </plain></SENT>
<SENT sid="6" pm="."><plain>We tested the therapeutic supremacy of MLCDP over liposomal <z:chebi fb="0" ids="16436,49086">CDP-Choline</z:chebi> (LCDP) in global moderate <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> reperfusion induced neuronal damage </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="16436,49086">CDP-Choline</z:chebi> in MLCDP delivery system was found potent to exert substantial protection against global moderate <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> reperfusion induced <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> damage in aged rat brain </plain></SENT>
<SENT sid="8" pm="."><plain>Membrane <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation, GSSG/GSH ratio and reactive oxygen species (ROS) generation in cerebral tissue were found to be higher in aged, compared to young rat </plain></SENT>
<SENT sid="9" pm="."><plain>Further decline of those parameters was observed in aged rat brain by the induction of global moderate <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and reperfusion </plain></SENT>
<SENT sid="10" pm="."><plain>MLCDP treatment when compared to free or LCDP treatment prevented global moderate <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfusion induced <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> damage as evident ultra structurally and release of <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> (<z:chebi fb="0" ids="16040">cyt</z:chebi> c) from mitochondria into cytosol and protected mitochondria to restore its <z:mpath ids='MPATH_458'>normal</z:mpath> structure and functions </plain></SENT>
</text></document>